Drugs and Devices

FDA approves new device that may boost number of lung transplants

On August 12, the U.S. Food and Drug Administration (FDA) approved the XVIVO Perfusion System (XPS) with STEEN Solution, a device for preserving donated lungs that do not initially meet the standard criteria for lung transplantation but may be transplantable if there is more time to observe and evaluate the organ’s function to determine whether the lung is viable for transplantation. Read more.

Shares



Related Articles:

Leave a Reply

Your email address will not be published. Required fields are marked *

 

Shares